Russia to Administer Melanoma Vaccines to 20 Patients
Moscow, Aug 30 - Treatment of the first patient who received the Russian melanoma vaccine is proceeding successfully, said Alexander Ginzburg, scientific director of the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei under the Ministry of Health of the Russian Federation, to RIA Novosti.
Consensus
- Russia plans to administer melanoma vaccines to at least twenty patients by the end of 2026.
- Twelve patients have already undergone diagnosis and have individual mRNA vaccine schemes developed and synthesized.
- The vaccines are in the final stages of preparation and will be transferred to the Gertsen Oncology Center in September–October.
- The Gertsen Oncology Center will receive the vaccines for treatment of melanoma patients.
- The first patient is expected to complete vaccination by September 2026.
Points of divergence
- On August 3, information emerged about the development of a prototype oncovaccine for non-small cell lung cancer by staff at the Gamaleya Center, based on the same scheme used for the melanoma vaccine. — vm
- The Gertsen Oncology Center plans to begin treatment for at least 20 patients by the end of the 2026 calendar year. — vesti
Coverage (5 sources)
- It has become known the condition of the first patient vaccinated against skin cancer in Russia — Вести
- Ginzburg spoke about plans to use melanoma vaccines — РИАМО
- Ginzburg: Vaccines against melanoma synthesized for 12 more patients in Russia — Вечерняя Москва
- In Russia, individual vaccines were prepared for 12 patients with skin cancer — Вести
- New melanoma vaccines synthesized for 12 patients — Москва 24
Key entities
- Russia
- Alexander Ginzburg
- RIA Novosti
- Moscow
- Ministry of Health
- RAS
- Gamaleya Research Institute of Epidemiology and Microbiology
- National Research Center for Epidemiology and Microbiology (NRECM) named after N.F. Gamalei
- Herzen
- Yulia Ivanko Vaccina
- Gamaleya Institute
- Moscow Scientific Research Oncological Institute named after Herzen
- National Research Center for Epidemiology and Microbiology named after N.F. Gamalei
- Gercen Scientific Research Oncological Institute
More on Alexander Ginzburg
- Melanoma, lung small-cell carcinoma, bladder cancer, and colorectal…
- Ginzburg, the scientific director of the NitsEM named
- Scientists at the National Research Center for Epidemiology and…